查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1999374

家庭输液服务市场：2026-2032年全球市场预测（按服务类型、交付方式、给药途径、治疗方法和最终用户划分）

Home Infusion Services Market by Service Type, Delivery Mode, Route Of Administration, Therapy Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年家庭输液服务市场价值为 263.2 亿美元，预计到 2026 年将成长至 285.6 亿美元，复合年增长率为 10.35%，到 2032 年将达到 524.9 亿美元。

主要市场统计数据
基准年 2025 263.2亿美元
预计年份：2026年 285.6亿美元
预测年份：2032年 524.9亿美元
复合年增长率 (%) 10.35%

简要概述临床进步、营运创新和支付方趋势如何重塑家庭静脉输液在整个护理连续体中的作用。

随着临床实务日益复杂，护理模式也从传统的医院环境转向患者家中，居家静脉输液服务的模式正在迅速变化。输液疗法的进步，以及静脉输液设备便携性的提升和报销管道的拓展，使得门诊和居家静脉及皮下输液疗法成为综合患者照护中日益重要的组成部分。医疗服务提供者正在积极应对这一变化，调整其护理模式，在确保安全性、连续性和成本效益的同时，维持与机构护理同等的临床绩效标准。

数位医疗、小型输液技术和监管调整将如何共同推动分散式输液护理的模式转移？

技术创新、监管调整和患者偏好的改变正在改变输液治疗的实施方式。居家照护不再是小众选择，而是逐渐成为减少住院次数、改善病患体验的重要策略选择。小型携带式输液帮浦和皮下给药技术的引入，以及病患教育和远距临床监测的改进，正在拓展可在院外安全进行的治疗方法范围。

美国关税政策的演变对家庭输液服务提供者和临床项目的医疗设备和耗材供应链的累积营运影响。

2025年的关税调整对整个输液护理供应链都产生了影响，包括输液帮浦、一次性用品和无菌配製原料的采购。进口医疗设备和原料关税的提高，使得传统上依赖全球製造地的医疗机构和供应商的采购流程变得更加复杂。因此，采购团队正在重新审视其供应商组合和合约结构，以降低关税相关的成本波动和交货延迟带来的风险。

关键细分洞察显示管理方法、最终用户环境、管理途径、服务类型和治疗类型如何共同塑造营运和临床策略。

細項分析揭示了基于给药方式、最终用户、给药途径、服务类型和治疗类别的不同操作和临床考虑。给药方式（静脉注射与皮下注射）的差异会影响医疗设备的选择、照护者的能力、监测强度。静脉输液治疗通常需要更进阶的监测，而皮下注射则允许更广泛的门诊给药。不同最终用户（诊所、居家医疗和医院）的差异导致了人员配备模式、认证程序和物流网络的差异，所有这些都必须进行调整以确保有效的护理过渡。

美洲、欧洲、中东和非洲以及亚太地区的机会和限制决定了部署管道和营运规模。

区域趋势正在改变家庭静脉输液服务的引入和推广方式，每个区域（美洲、欧洲、中东和非洲以及亚太地区）都面临不同的驱动因素和限制因素。在美洲，与门诊报销框架一致的监管环境以及完善的居家医疗基础设施促进了静脉输液服务的快速普及，而人口老龄化和慢性病患病率的上升则持续推高了对门诊治疗的需求。相较之下，由于报销体系和医疗服务结构的差异，欧洲、中东和非洲的情况则有所不同。一些国家优先发展集中式医院服务，而另一些国家则正在尝试利用远端医疗和社区护理网络，建立分散式静脉输液管道。

策略伙伴关係、对认证的重视以及数位化如何影响静脉输液生态系统中企业的竞争差异化和能力发展？

家庭输液生态系统的企业级发展趋势以策略联盟、能力差异化以及对临床和供应链能力的定向投资为特征。医疗服务提供者正与专科药房、医疗设备製造商和技术供应商合作，建立整合式护理路径，以减少交接环节并提高护理连续性。同时，拥有强大数位监测平台的新兴参与企业正凭藉其主导数据分析的用药依从性和安全性监测功能，为护理服务提供补充，从而迅速发展壮大。

领导者为确保家庭静脉输液服务的供应弹性、临床能力和报销系统的一致性而采用的实用营运和策略建议。

产业领导者应采取一系列切实可行的措施，在确保临床标准和营运连续性的同时，最大限度地发挥分散式输液的优势。首先，领导者需要有系统地建立供应商多元化和近岸筹资策略，以减轻关税造成的供应中断。同时，他们应实施库存管理框架，在不增加不必要资本负担的情况下，维持临床实务的可近性。其次，对人力资源发展的投入至关重要。临床医生和药剂师需要标准化的能力发展计划，涵盖血管通路管理、输液装置操作和远端分流通讯协定。

透过结合相关人员访谈、监管趋势分析和交叉检验，采用高度透明的混合方法，可以获得可靠的营运见解，用于输液计画。

本报告的调查方法融合了质性访谈、第二手资料整合和三角验证，以确保获得可靠且可操作的洞见。主要资讯透过对临床医生、药房负责人、采购主管和居家医疗管理人员的结构化检验收集，以了解实际营运中的挑战和策略重点。此外，还对监管指南、设备规格和专业标准进行了系统性审查，以确保临床建议符合一般安全和品质预期。

此概要概述了永续家庭输液护理实践的未来前景，重点关注临床卓越性、供应链韧性和数位监测的整合。

随着临床能力、数位化监测和病患偏好日益趋于一致，居家输液服务将在现代医疗服务体系中发挥越来越重要的作用。其成功取决于医疗机构能否将无菌配製品质、护理专业知识和供应链韧性整合到符合支付方期望和监管标准的统一方案中。随着相关人员接受分散式输液管道，互通性、临床医生培训以及对病人安全的重视程度，很可能决定哪些模式能够有效且可持续地扩展。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 工业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：家庭输液服务市场：依服务类型划分

  • 药局服务
  • 护理服务
  • 病患监测

第九章：家庭输液服务市场：依交付方式划分

  • 静脉
  • 皮下

第十章：家庭输液服务市场：依给药途径划分

  • 中央静脉
  • 週边静脉

第十一章 家庭输液服务市场：依治疗方法

  • 抗生素滴注
    • Aminoglycosides
    • β-内酰胺
    • Fluoroquinolones
  • 肿瘤学
    • 静脉注射抗癌药物
    • 皮下注射抗癌药物
  • 疼痛管理
    • 非阿片类药物输注
    • 阿片类药物输注
  • 肠外营养
    • 週边静脉营养
    • 全静脉营养

第十二章 家庭输液服务市场：依最终用户划分

  • 诊所
  • 居家医疗护理
  • 医院

第十三章：家庭输液服务市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 家庭输液服务市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 家庭输液服务市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国家庭输液服务市场

第十七章：中国家庭输液服务市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Caesarea Medical Electronics Ltd.
  • CVS Health Corporation
  • Fresenius Kabi AG
  • ICU Medical, Inc.
  • InfuSystem Holdings, Inc.
  • JMS Co., Ltd.
  • Medtronic PLC
  • Moog Inc.
  • Nipro Corporation
  • Option Care Health, Inc.
  • Sichuan Consun Pharmaceutical Co., Ltd.
  • Terumo Corporation
Product Code: MRR-3A2E844FEC05

The Home Infusion Services Market was valued at USD 26.32 billion in 2025 and is projected to grow to USD 28.56 billion in 2026, with a CAGR of 10.35%, reaching USD 52.49 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 26.32 billion
Estimated Year [2026] USD 28.56 billion
Forecast Year [2032] USD 52.49 billion
CAGR (%) 10.35%

A concise orientation to how clinical advances, operational innovations, and payer dynamics are reshaping home infusion delivery across care continuums

The home infusion services landscape is evolving rapidly as clinical complexity shifts care beyond traditional inpatient settings and into patients' homes. Advances in infusion therapeutics, combined with enhanced portability of infusion devices and expanded reimbursement pathways, have made outpatient and home-based intravenous and subcutaneous therapies an increasingly viable component of comprehensive patient care. Providers are responding by reconfiguring care models to prioritize safety, continuity, and cost efficiency while maintaining clinical performance standards comparable to facility-based care.

As a result, stakeholders across clinical, operational, and payer communities are reassessing how infusion services are commissioned and delivered. Clinicians are integrating remote monitoring and telehealth to support nursing and medication administration workflows, whereas administrators are building partnerships with specialty pharmacies and compounding facilities to secure sterile preparations. Consequently, decision-makers must consider clinical competency, supply chain robustness, and regulatory compliance in parallel when designing scalable home infusion programs.

How digital health, compact infusion technologies, and regulatory adaptations collectively drive a paradigm shift toward decentralized infusion care

Care delivery for infusion therapies is undergoing transformative shifts as technological innovation, regulatory adjustments, and patient preferences converge. Home-based care is no longer a niche alternative; it is being embedded as a strategic option to reduce inpatient utilization and to improve patient experience. The adoption of compact ambulatory infusion pumps and subcutaneous administration techniques, alongside improvements in patient education and remote clinical oversight, has expanded the range of therapies that can be safely managed outside the hospital.

Meanwhile, regulatory frameworks are adapting to support decentralized care models, emphasizing quality metrics, safe compounding practices, and interoperability of clinical records. These shifts encourage integration between hospitals, outpatient clinics, and home healthcare entities and create incentives for care pathways that prioritize continuity and reduced readmission risk. In turn, healthcare leaders are investing in workforce training, digital monitoring, and process standardization to operationalize these transformative changes and to ensure consistent patient outcomes.

The cumulative operational consequences of evolving U.S. tariff policy on device and consumable supply chains for home infusion providers and clinical programs

Tariff policy adjustments in 2025 are creating ripples across supply chains that support infusion care, affecting procurement of infusion pumps, disposables, and sterile compounding inputs. Increased duties on imported medical devices and raw materials have raised sourcing complexity for providers and suppliers that historically relied on globalized manufacturing footprints. Consequently, procurement teams are reassessing vendor portfolios and contract structures to mitigate exposure to customs-related cost volatility and delivery delays.

In response, organizations are prioritizing supplier diversification, nearshoring of critical components, and strategic inventory buffering to maintain clinical continuity. Clinical leaders are collaborating with procurement and pharmacy stakeholders to validate alternative device options and to ensure compatibility with established clinical protocols. Over time, these adjustments are accelerating interest in domestic manufacturing partnerships and aggregated purchasing strategies that reduce transactional friction and support predictable supply flows for infusion services.

Critical segmentation insights that demonstrate how delivery mode, end user environment, administration route, service type, and therapy type jointly shape operational and clinical strategies

Segmentation analysis reveals differentiated operational and clinical considerations across delivery modes, end users, administration routes, service types, and therapy categories. Delivery mode distinctions between intravenous and subcutaneous pathways inform device selection, nursing competencies, and monitoring intensity, with intravenous therapies often requiring higher acuity oversight and subcutaneous options enabling broader outpatient administration. End user variation across clinics, home healthcare agencies, and hospitals translates to divergent staffing models, credentialing procedures, and logistical networks that must be coordinated for effective transitions of care.

Route of administration divides into central and peripheral approaches, shaping vascular access management, infection prevention protocols, and patient education priorities. Service types encompassing compounding services, nursing services, and patient monitoring form an integrated service architecture where sterile preparation quality feeds directly into nursing workflow efficiency and remote monitoring systems. Therapy-type groupings-antibiotic infusion, oncology, pain management, and parenteral nutrition-require therapy-specific clinical pathways; for example, antibiotic infusion spans aminoglycosides, beta-lactams, and fluoroquinolones with distinct pharmacokinetic and safety profiles, while oncology care differentiates between intravenous oncology agents and subcutaneous oncology agents, each presenting unique infusion scheduling and toxicity management needs. Pain management segregates into non-opioid and opioid infusion strategies, which necessitate different regulatory oversight and monitoring protocols, and parenteral nutrition splits into peripheral parenteral nutrition and total parenteral nutrition, each with distinct metabolic monitoring and catheter considerations.

Taken together, these segmentation dimensions inform how providers design clinical protocols, allocate capital for devices and compounding capacity, and structure care bundles that align with payer requirements and patient-centered outcomes. Consequently, stakeholders must tailor operational models and quality assurance mechanisms to the specific intersection of delivery mode, end user environment, administration route, service type, and therapy characteristics to ensure safe, efficient, and patient-focused infusion care.

Regional opportunities and constraints across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine adoption pathways and operational scalability

Regional dynamics are reshaping how home infusion services are implemented and scaled, with distinct drivers and constraints across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, regulatory alignment with outpatient reimbursement frameworks and established home health infrastructures supports rapid uptake of infusion services, while population aging and chronic disease prevalence create sustained demand for ambulatory therapy delivery. Meanwhile, Europe, Middle East & Africa displays heterogeneity driven by divergent reimbursement regimes and healthcare delivery structures; some national systems prioritize centralized hospital services while others are piloting decentralized infusion pathways supported by telehealth and community nursing networks.

In Asia-Pacific, rapid development of domestic medical manufacturing, expansion of private healthcare providers, and growing investments in digital health platforms are enabling broader access to home-based infusion care, although variability in regulatory standards and workforce capacity can constrain uniform deployment. Across regions, differences in supply chain resilience, device approval timelines, and local compounding capabilities influence the speed and scale at which home infusion models can be integrated. Therefore, regional strategy must account for payer structures, workforce readiness, and regulatory alignment to successfully operationalize home infusion programs.

How strategic partnerships, accreditation focus, and digital enablement are shaping competitive differentiation and capability development among firms in the infusion ecosystem

Company-level dynamics in the home infusion ecosystem are characterized by strategic collaborations, capability differentiation, and targeted investments in clinical and supply chain capabilities. Providers are forming alliances with specialty compounding pharmacies, device manufacturers, and technology vendors to build integrated care pathways that reduce handoffs and improve continuity. At the same time, entrants with strong digital monitoring platforms are gaining traction by offering analytics-driven adherence and safety oversight that complement nursing services.

Competitive differentiation often centers on service breadth, compliance rigor, and the ability to deliver complex therapies with consistent clinical outcomes. Leaders prioritize accreditation, standardized compounding processes, and rigorous training programs to support higher-acuity home infusions. Additionally, firms that invest in interoperability with electronic health records and telehealth platforms enhance care coordination and reduce administrative friction. In sum, the corporate landscape favors organizations that can combine clinical excellence, supply chain resilience, and digital enablement to support a wide range of therapy types and care settings.

Actionable operational and strategic recommendations for leaders to secure supply resilience, clinical competency, and reimbursement alignment in home infusion services

Industry leaders should adopt a set of pragmatic actions to capitalize on decentralized infusion opportunities while safeguarding clinical standards and operational continuity. First, leaders must institutionalize supplier diversification and nearshore sourcing strategies to mitigate tariff-driven supply disruptions; simultaneously, they should implement inventory governance frameworks that preserve clinical access without creating unnecessary capital burden. Second, investment in workforce development is essential: clinicians and pharmacy staff require standardized competency programs that address vascular access management, infusion device operation, and remote triage protocols.

Moreover, organizations should prioritize integration of remote monitoring and telehealth into core service pathways to support earlier discharge and reduce readmission risk. Cross-functional governance that aligns clinical, pharmacy, and procurement functions will accelerate adoption of new therapies and devices while ensuring regulatory compliance. Finally, payers and providers should collaborate on reimbursement models that recognize the value of home infusion in patient-centered care, incentivizing outcomes-focused contracting and shared risk arrangements that reward quality and continuity of care.

Transparent mixed-methods approach combining stakeholder interviews, regulatory synthesis, and cross-validation to produce reliable operational insights for infusion programs

The research methodology underpinning this report integrates primary qualitative interviews, secondary document synthesis, and triangulated validation to ensure robust, actionable findings. Primary inputs were gathered through structured interviews with clinicians, pharmacy leaders, procurement executives, and home healthcare administrators to capture frontline operational challenges and strategic priorities. These insights were supplemented by a systematic review of regulatory guidance, device specifications, and professional standards to ensure clinical recommendations align with prevailing safety and quality expectations.

Analytical processes included cross-validation of interview themes with observed industry initiatives and public policy shifts, enabling identification of emergent patterns without relying on singular data sources. Throughout the process, careful attention was given to data provenance and potential bias mitigation, ensuring that findings reflect a balanced synthesis of stakeholder perspectives and documented practice. This blended methodology supports practical recommendations and a nuanced understanding of operational levers that influence successful deployment of home infusion services.

A forward-looking summary emphasizing integration of clinical excellence, supply chain resilience, and digital monitoring to operationalize sustainable home infusion care

Home infusion services are positioned to play an increasingly central role in modern care delivery as clinical capabilities, digital monitoring, and patient preferences continue to align. Success will depend on the ability of healthcare organizations to integrate sterile compounding quality, nursing competency, and supply chain resilience into coherent programs that meet payer expectations and regulatory standards. As stakeholders adopt decentralized infusion pathways, emphasis on interoperability, clinician training, and patient safety will determine which models scale effectively and sustainably.

Looking ahead, the convergence of device miniaturization, expanded subcutaneous therapy options, and remote oversight mechanisms will broaden the therapeutic scope suitable for home administration. Nevertheless, operational prudence-manifested as diversified sourcing, rigorous accreditation, and outcome-focused contracting-will remain essential to translating clinical potential into reliable, patient-centered care delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Home Infusion Services Market, by Service Type

  • 8.1. Compounding Services
  • 8.2. Nursing Services
  • 8.3. Patient Monitoring

9. Home Infusion Services Market, by Delivery Mode

  • 9.1. Intravenous
  • 9.2. Subcutaneous

10. Home Infusion Services Market, by Route Of Administration

  • 10.1. Central
  • 10.2. Peripheral

11. Home Infusion Services Market, by Therapy Type

  • 11.1. Antibiotic Infusion
    • 11.1.1. Aminoglycosides
    • 11.1.2. Beta Lactams
    • 11.1.3. Fluoroquinolones
  • 11.2. Oncology
    • 11.2.1. Intravenous Oncology Agents
    • 11.2.2. Subcutaneous Oncology Agents
  • 11.3. Pain Management
    • 11.3.1. Non Opioid Infusion
    • 11.3.2. Opioid Infusion
  • 11.4. Parenteral Nutrition
    • 11.4.1. Peripheral Parenteral Nutrition
    • 11.4.2. Total Parenteral Nutrition

12. Home Infusion Services Market, by End User

  • 12.1. Clinics
  • 12.2. Home Healthcare Agencies
  • 12.3. Hospitals

13. Home Infusion Services Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Home Infusion Services Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Home Infusion Services Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Home Infusion Services Market

17. China Home Infusion Services Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. B. Braun Melsungen AG
  • 18.6. Baxter International Inc.
  • 18.7. Becton, Dickinson and Company
  • 18.8. Caesarea Medical Electronics Ltd.
  • 18.9. CVS Health Corporation
  • 18.10. Fresenius Kabi AG
  • 18.11. ICU Medical, Inc.
  • 18.12. InfuSystem Holdings, Inc.
  • 18.13. JMS Co., Ltd.
  • 18.14. Medtronic PLC
  • 18.15. Moog Inc.
  • 18.16. Nipro Corporation
  • 18.17. Option Care Health, Inc.
  • 18.18. Sichuan Consun Pharmaceutical Co., Ltd.
  • 18.19. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HOME INFUSION SERVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HOME INFUSION SERVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COMPOUNDING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COMPOUNDING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COMPOUNDING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NURSING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NURSING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NURSING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PATIENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PATIENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CENTRAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CENTRAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CENTRAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY AMINOGLYCOSIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY AMINOGLYCOSIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY BETA LACTAMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY BETA LACTAMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY BETA LACTAMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY FLUOROQUINOLONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY FLUOROQUINOLONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS ONCOLOGY AGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS ONCOLOGY AGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS ONCOLOGY AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS ONCOLOGY AGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS ONCOLOGY AGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS ONCOLOGY AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NON OPIOID INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NON OPIOID INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NON OPIOID INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY OPIOID INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY OPIOID INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY OPIOID INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. GCC HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GCC HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. GCC HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 175. GCC HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 176. GCC HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. GCC HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 178. GCC HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. GCC HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 180. GCC HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 181. GCC HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. G7 HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. G7 HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. G7 HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 205. G7 HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 206. G7 HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. G7 HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 208. G7 HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. G7 HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 210. G7 HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 211. G7 HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. NATO HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. NATO HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. NATO HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 215. NATO HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 216. NATO HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. NATO HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 218. NATO HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 219. NATO HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 220. NATO HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 221. NATO HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)